Literature DB >> 7633720

Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia.

J J Coalson1, V Winter, R A deLemos.   

Abstract

In this study, 12 male baboons were delivered by hysterotomy at 75% of gestation. The development of a nonlethal baboon model permitted a study of lung growth and development in long-term survivors. Control animals were ventilated with clinically appropriate oxygen for the 21 d study period. BPD animals were ventilated with PPV and an FIO2 of 1.0 for 7 d, followed by an FIO2 of 0.8 for 14 d. They survived for 33 wk, at which time a right lower lobe lobectomy was performed. Controls showed normal well-alveolated lungs, whereas BPD lungs showed enlarged airspaces focally, nonclassifiable as alveoli, alveolar ducts, or respiratory bronchioles. Volume densities of alveoli were decreased significantly (p = 0.0009), and enlarged airspaces were significantly increased (p = 0.0003) in the BPD group compared with controls. Alveolar counts verified a significant decrease in alveoli (p = 0.004), and the internal surface area was significantly decreased (p = 0.05) in BPD treated animals compared with controls. These data document that a mild to moderate BPD lesion results in a significant and permanent loss of alveoli and a significant increase in enlarged, unclassifiable airspaces, which together result in a decreased total internal surface area in baboons that survive with their disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7633720     DOI: 10.1164/ajrccm.152.2.7633720

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  55 in total

Review 1.  Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy).

Authors:  E Eber; M S Zach
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

Review 2.  Lung growth: implications for the newborn infant.

Authors:  S Kotecha
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-01       Impact factor: 5.747

3.  Long term consequences of oxygen therapy in the neonatal period.

Authors:  Alan H Jobe; Suhas G Kallapur
Journal:  Semin Fetal Neonatal Med       Date:  2010-05-10       Impact factor: 3.926

Review 4.  Epigenetics and the developmental origins of lung disease.

Authors:  Lisa A Joss-Moore; Kurt H Albertine; Robert H Lane
Journal:  Mol Genet Metab       Date:  2011-07-23       Impact factor: 4.797

Review 5.  Chronic lung disease in the preterm infant. Lessons learned from animal models.

Authors:  Anne Hilgendorff; Irwin Reiss; Harald Ehrhardt; Oliver Eickelberg; Cristina M Alvira
Journal:  Am J Respir Cell Mol Biol       Date:  2014-02       Impact factor: 6.914

6.  Very prematurely born infants wheezing at follow-up: lung function and risk factors.

Authors:  Simon Broughton; Mark R Thomas; Louise Marston; Sandra A Calvert; Neil Marlow; Janet L Peacock; Gerrard F Rafferty; Anne Greenough
Journal:  Arch Dis Child       Date:  2007-09       Impact factor: 3.791

7.  Resuscitation of preterm neonates with limited versus high oxygen strategy.

Authors:  Vishal S Kapadia; Lina F Chalak; John E Sparks; James R Allen; Rashmin C Savani; Myra H Wyckoff
Journal:  Pediatrics       Date:  2013-11-11       Impact factor: 7.124

8.  Effects of a superoxide dismutase mimetic on biomarkers of lung angiogenesis and alveolarization during hyperoxia with intermittent hypoxia.

Authors:  Michael Chang; Fayez Bany-Mohammed; M Cristina Kenney; Kay D Beharry
Journal:  Am J Transl Res       Date:  2013-09-25       Impact factor: 4.060

9.  Catch-up alveolarization in ex-preterm children: evidence from (3)He magnetic resonance.

Authors:  Manjith Narayanan; Caroline S Beardsmore; John Owers-Bradley; Cristian M Dogaru; Marius Mada; Iain Ball; Ruslan R Garipov; Claudia E Kuehni; Ben D Spycher; Michael Silverman
Journal:  Am J Respir Crit Care Med       Date:  2013-05-15       Impact factor: 21.405

Review 10.  The role of hyperoxia in the pathogenesis of experimental BPD.

Authors:  Bradley W Buczynski; Echezona T Maduekwe; Michael A O'Reilly
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.